Connection
Shmuel Yaccoby to Antibody-Dependent Cell Cytotoxicity
This is a "connection" page, showing publications Shmuel Yaccoby has written about Antibody-Dependent Cell Cytotoxicity.
|
|
Connection Strength |
|
|
|
|
|
0.022 |
|
|
|
-
van Rhee F, Szmania SM, Dillon M, van Abbema AM, Li X, Stone MK, Garg TK, Shi J, Moreno-Bost AM, Yun R, Balasa B, Ganguly B, Chao D, Rice AG, Zhan F, Shaughnessy JD, Barlogie B, Yaccoby S, Afar DE. Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. Mol Cancer Ther. 2009 Sep; 8(9):2616-24.
Score: 0.022